EcoR1 Capital, LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 120 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
EcoR1 Capital, LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q4 2021$81,265,000
+35.3%
6,319,232
+13.6%
2.59%
+24.0%
Q3 2021$60,056,000
+92.3%
5,560,748
+62.5%
2.09%
+79.0%
Q2 2021$31,236,000
-3.2%
3,421,2870.0%1.17%
-18.4%
Q1 2021$32,263,000
+139.3%
3,421,2870.0%1.43%
+97.4%
Q4 2020$13,480,0003,421,2870.72%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$17,536,0001.82%
EcoR1 Capital, LLC 3,421,287$13,480,0000.72%
FRAZIER MANAGEMENT LLC 2,061,758$8,123,0000.63%
BVF INC/IL 2,695,418$10,620,0000.42%
Column Group LLC 869,493$3,426,0000.31%
Avidity Partners Management LP 2,122,064$8,361,0000.27%
Redmile Group, LLC 3,059,794$12,056,0000.15%
SkyOak Wealth, LLC 69,778$275,0000.09%
Tekla Capital Management LLC 419,005$1,651,0000.06%
Blackstone Inc. 2,567,445$10,116,0000.04%
View complete list of GRITSTONE ONCOLOGY INC shareholders